Media Hits

BME Professor Charlie Gersbach is one of several researchers worldwide interviewed for an article on using CRISPR to influence gene expression by editing the epigenome with the goal of treating disease.

Sharon Gerecht and her laboratory have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time.

Jessilyn Dunn weighs in on what it takes for data gathered by wearables like blood pressure to be actionable in clinical settings as apps begin connecting users to physicians.

Amy Gladfelter describes her work studying "extreme cells" that break many of the rules of biology and may hold clues to pregnancy complications, certain diseases, and even cancer.

Gladfelter, a Duke Health Distinguished Professor of Cell Biology and Biomedical Engineering, is a quantitative cell biologist interested in fundamental mechanisms of cell organization

There’s no appreciable difference in people’s number of daily steps before and after a time change, according to Fitbit data drawn from 1,157 people in four U.S. states.

From 3D printed braces used by the NFL to a gel that can help regrow bones, all kinds of innovations are coming out of a Duke incubator called the BRiDGE.

Learn about the journey from academic researcher to entrepreneur and what it takes to launch a successful spin-out company, from Ashutosh Chilkoti, a serial founder

Sharon Gerecht's lab shows how OCT and AI can be used to track wound healing better than ever before.

Led by Nicole Pelot, Warren Grill's lab improves 3D models of vagus nerves for stimulation treatment by using full 3D scans rather than just a single cross-section in their work.

Amanda Randles simulates blood flow at the level of individual red blood cells, sometimes hundreds of millions of them across simulations spanning roughly 700,000 heartbeats.

Amanda Randles explains how she uses physics-based, computationally intensive simulations to develop new ways to diagnose and treat human disease.